Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Azenta Community
NasdaqGS:AZTA Community
1
Narratives
written by author
0
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Community Investing Ideas
Azenta
Popular
Undervalued
Overvalued
Azenta
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Personalized Medicine And Automation Will Drive Future Market Expansion
Key Takeaways Strong growth driven by personalized medicine, automation, and outsourcing trends, with recurring revenue and margin expansion from stable pricing and digital modernization. Operational efficiency, strategic investments, and disciplined portfolio management are fueling both cost control and sustainable long-term earnings resilience.
View narrative
US$33.00
FV
7.9% undervalued
intrinsic discount
0.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
AZTA
AZTA
Azenta
Your Fair Value
US$
Current Price
US$30.39
39.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-168m
850m
2015
2018
2021
2024
2025
2027
2030
Revenue US$708.7m
Earnings US$90.7m
Advanced
Set Fair Value